AntimicrobialInvestigational

Gramicidin S

Topical

Overview

Gramicidin S is a cyclic decapeptide antibiotic isolated from Bacillus brevis, consisting of two identical pentapeptide sequences joined in a ring structure. The peptide exerts antimicrobial activity by disrupting bacterial cell membrane integrity through interaction with phospholipid bilayers, leading to leakage of cellular contents.

Mechanism of Action

Its amphipathic beta-sheet conformation enables selective insertion into bacterial membranes. The compound demonstrates broad-spectrum activity against both Gram-positive and Gram-negative organisms..

Research Summary & Key Findings

Gramicidin S has been used primarily as a topical antimicrobial agent in certain countries, particularly in the former Soviet Union, but is not FDA approved for systemic use due to hemolytic toxicity and nephrotoxicity. In vitro studies have confirmed potent activity against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Staphylococcus aureus. Current research focuses on structural analogs with improved therapeutic indices for potential topical or surface decontamination applications.

Clinical Status

Investigational

Gramicidin S is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.

Administration Routes

Topical

Related Peptides in Antimicrobial

Find a Provider

Find a verified provider who offers Gramicidin S therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Gramicidin S.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.